CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-14 | Dier Mardi CFO & Executive Vice President | Sale | −1,629 | $40.16 | $65K | 66,695 |
| 2022-10-12 | Dier Mardi CFO & Executive Vice President | Sale | −3,484 | $38.22 | $133K | 68,324 |
| 2022-09-16 | Dier Mardi CFO & Executive Vice President | Grant or award | +20,000 | 71,808 | ||
| 2022-09-01 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Grant or award | +1,000 | 18,094 | ||
| 2022-06-24 | Sanders Corazon (Corsee) D. Director | Grant or award | +3,300 | 7,195 | ||
| 2022-06-24 | Sanders Corazon (Corsee) D. Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | WELCH DANIEL G Director | Grant or award | +3,300 | 17,745 | ||
| 2022-06-24 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | Ekman Lars Director | Grant or award | +3,300 | 17,745 | ||
| 2022-06-24 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | Fust Matthew K Director | Grant or award | +3,300 | 26,495 | ||
| 2022-06-24 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | NARACHI MICHAEL Director | Grant or award | +3,300 | 17,745 | ||
| 2022-06-24 | NARACHI MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | Ray Amrit Director | Grant or award | +3,300 | 8,420 | ||
| 2022-06-24 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | SULIMAN SHEHNAAZ Director | Grant or award | +3,300 | 10,995 | ||
| 2022-06-24 | SULIMAN SHEHNAAZ Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-06-24 | Dunsire Deborah Director | Grant or award | +3,300 | 15,870 | ||
| 2022-06-24 | Dunsire Deborah Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 |
Page 15 of 21 · 410 trades